SCHEMBL6508516

SCHEMBL6508516

CC(C)(CC[S+]([O-])c1ccc([S+]([O-])CCC(C)(C)C(=O)O)cc1)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 11/20 0.37
CYP2C9 P11712 3/20 0.36
CYP1A2 P05177 2/20 0.36
TTR P02766 1/20 0.36
CYP2C8 P10632 1/20 0.36
CHRM1 P11229 1/20 0.36
TSHR P16473 1/20 0.36
ADRA1A P35348 1/20 0.36
PPARG P37231 1/20 0.36
HTR2B P41595 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLCO1B3 Q9NPD5 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CISD1 Q9NZ45 1/20 0.36
SLCO1B1 Q9Y6L6 1/20 0.36
ACLY P53396 1/20 0.35
GUCY1A1 Q02108 1/20 0.35
GUCY1B1 Q02153 1/20 0.35
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6533760 0.81 KCNN4 (0.33)
SCHEMBL11092745 0.79 PPARA (0.60) PPARACYP2C9CYP1A2TTRCYP2C8
SCHEMBL7202384 0.78 ELANE (0.44) PPARATDP1
SCHEMBL6899108 0.76 ALDH1A1 (0.38)
SCHEMBL6502073 0.76 ALDH1A1 (0.44) TSHRSMN1; SMN2TDP1
SCHEMBL6711509 0.75 PPARA (0.37) PPARACYP2C9CYP1A2TTRCYP2C8
SCHEMBL13038658 0.74 PPARA (0.37) PPARACYP2C9CYP1A2TSHRSMN1; SMN2
SCHEMBL6532719 0.74 ACLY (0.41) PPARACYP2C9CYP1A2TTRCYP2C8
SCHEMBL25007220 0.71 RIPK1 (0.38)
SCHEMBL6692621 0.71 ACLY (0.42) PPARACYP2C9CYP1A2TTRCYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005047236-A1 SULFOXIDE AND BIS-SULFOXIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-05-26 WO disclosed
US-6673780-B2 SUCH AS 4-(4-(3-HYDROXY-3-METHYL-BUTANE-1-SULFINYLMETHYL)-PHENYLMETHANESULFINYL)-2 -METHYL-BUTAN1-OL FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES, DYSLIPIDEMIAS, DYSPROTEINEMIAS, AND GLUCOSE METABOLISM DISORDERS ESPERION THERAPEUTICS, INC. 2004-01-06 US disclosed